Med Life (BSE:M) FFO


BSE:M Med Life SA BSE:M
91 GF Score
Price lei11.40
GF Value lei7.82
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Med Life FFO?

FFO (Funds from operations) only applies to REITs.

BSE:M
91GF Score
Med Life SA BSE:M
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Med Life (BSE:M) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei11.40 is trading 45.8% above its estimated GF Value™ of lei7.82. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for BSE:M:

  • FFO:
  • GF Value™: lei7.82 vs. price of lei11.40 (45.8% above fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Med Life Business Description

Other Exchanges 0RO5:UKO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
91GF Score

Get the complete analysis for BSE:M

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei11.40
Price
lei7.82
GF Value